29Jul
What is JSMFETF and is it a good long-term investment?
In 2024, the JS Momentum Factor ETF, known as JSMFETF, had an incredible run. Its performance caught the eye of many retail investors and poured…
28Jul
The limit of compounding
How Often Should You Get Paid? The Math Behind Compounding and Dividend Frequency Compounding is one of the most powerful ideas in investing. The longer you reinvest…
23Jul
Top 3 sectors to trade in according to analysts
Wondering where the research houses want their clients to put their money in? If you are a trader and looking to maximize your gains
12Jul
Top 5 High ROE Picks According to Topline Securities
Looking for value in a rising market? As the KSE-100 scales new highs and investor optimism returns, finding cheap stocks gets harder,
11Jul
These 5 Could Soar in FY26 according to Arif Habib Limited
Arif Habib Limited (AHL), one of Pakistan’s leading brokerage houses, has crunched the numbers and published its outlook on stocks with the highest total return…
11Jul
Debt buyback program: Repayment of Rs 1.5 trillion Public Debt
The Debt Management Office (DMO) took a major stride by executing an early retirement of Rs 500 billion of domestic debt. The amount, which was borrowed from…
09Jul
Retail Investor Participation in Pakistan’s Evolving Equity Landscape.
Over the past few years, Pakistan’s stock market has witnessed a remarkable transformation as retail investors have emerged from the shadows to become a central…
07Jul
Why Local Drugmakers Took Over: A History of Pharma Policy in Pakistan
Deregulation of non-essential drug prices back in early 2024, captivated many retail pharmaceutical industry stakeholders. This helped industry sales cross PKR 1 trillion mark⚠️ This post reflects the author’s personal opinion and is for informational purposes only. It does not constitute financial advice. Investing involves risk and should be done independently. Read full disclaimer →